glp-1 cardiovascular outcomes trial august 2025 Emerging Frontiers in Therapeutics: A Comprehensive Evidence Base ( 2025) glp-1 cardiovascular outcomes trial results

What is the MinuteClinic Weight-Loss Program

A single-component research material supplied for controlled research environments

For perspective, prior to 2023, the top-selling drugs were largely immunology or oncology biologics (like Humira, Keytruda, Eliquis), but by mid-2024, the list transformed GLP-1 agonists entered the top ranks

10.1016/j.metabol.2022.155309 Metabolism

Thats where Ivim Healths GLP-1 ID program comes in

Multi-incretin constructs are typically designed to co-activate GLP-1 receptors, GIP receptors, and sometimes the glucagon receptor, with balanced potency chosen to test specific hypotheses about energy expenditure vs